"[T]his [data] represents the first-ever evidence from Europe on the substitution effects induced by a compound of cannabis, CBD."
Topic: CBD
"These findings may have implications for the potential use of CBD across a range of disorders, including Alzheimer’s disease, PTSD and depression."
"The current findings indicate that improved seizure control can be obtained without adversely affecting cognitive or adaptive functioning."
Daily doses of 400 mg of CBD decreased the number of cannabis cigarettes that subjects smoked per week.
The law states that "a patient who qualifies for a CBD-rich card may only receive cannabidiol-rich medical marijuana products."
Lab analyses confirmed that only 45 percent of products contained actual amounts of CBD that were consistent with their advertising.
The law expands the pool of patients eligible for licensed CBD products to include those with post-traumatic stress and chronic pain conditions, and make other changes.
More than one in four of products possessed levels of CBD that differed by more than ten percent from what was advertised.